Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Metastatic melanoma is a deadly malignancy with poor outcomes historically. Immuno-oncology (IO) agents, targeting immune checkpoint molecules such as cytotoxic T-lymphocyte associated protein-4 (CTLA-4) and programmed cell death-1 (PD-1), have revolutionized melanoma treatment and outcomes, achievi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Robert A. Szczepaniak Sloane, Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han, Elizabeth Burton, Nadim Ajami, Julie M. Simon, Chantale Bernatchez, Lauren E. Haydu, Hussein A. Tawbi, Jeffrey E. Gershenwald, Emily Keung, Merrick Ross, Jennifer McQuade, Rodabe N. Amaria, Khalida Wani, Alexander J. Lazar, Scott E. Woodman, Linghua Wang, Miles C. Andrews, Jennifer A. Wargo
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
microRNA
melanoma
immune checkpoint blockade
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/c8064d6d4da44883816ebcc8ea0a1965
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/c8064d6d4da44883816ebcc8ea0a1965

Documents similaires